Sustained reduction in myocardial reperfusion injury with an adenosine receptor antagonist: Possible role of the neutrophil chemoattractant response

Journal of Pharmacology and Experimental Therapeutics

Volumn 292, Issue 3, 2000, Pages 929-938

  Forman, Mervyn B ^b   Vitola, João V ^b   Velasco, Carlos E ^b   Murray, John J ^b   Dubey, Raghvendra K ^a   Jackson, Edwin K ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE RECEPTOR BLOCKING AGENT; CHEMOATTRACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; FEMALE; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART PROTECTION; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; REPERFUSION INJURY;

ANIMALS; CORONARY CIRCULATION; DOGS; FEMALE; MALE; MYOCARDIAL REPERFUSION INJURY; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; RECEPTORS, PURINERGIC P1; XANTHINES;

EID: 0034008519     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. 1-receptors in rat brain. Pharmacol Res Commun 19:537-545.
2. Babbitt DG, Virmani R and Forman MB (1989) Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model. Circulation 80:1388-1399.
3. Connelly C, Vogel WM, Hernandez YM and Apstein CS (1982) Movement of necrotic wavefront after coronary artery occlusion in rabbit. Am J Physiol 243:H682-H690.
4. 2 generation, respectively. J Clin Invest 85:1150-1157.
5. 2-adenosine receptors. J Med Chem 28:487-492.
6. Dalziel HH and Westfall DP (1994) Receptors for adenine nucleotides and nucleosides: Subclassification, distribution, and molecular characterization. Pharmacol Rev 46:449-466.
7. Domenech RJ, Macho P, Velez D, Sanchez G, Liu X and Dhalla N (1998) Tachycardia preconditions infarct size in dogs: Role of adenosine and protein kinase C. Circulation 97:786-794.
8. 2B receptors. Hypertension 31: 943-948.
9. Ely SW and Berne RM (1992) Protective effects of adenosine in myocardial ischemia. Circulation 85:893-904.
10. Forman MB, Bingham S, Kopelman HA, Wehr C, Sandler MP, Kolodgie F, Vaughn WK, Friesinger GC and Virmani R (1985) Reduction of infarct size with intracoronary perfluorochemical in a canine preparation of reperfusion. Circulation 71: 1060-1068.
11. Forman MB and Murray JJ (1997) Pathogenesis and modification of myocardial stunning and reperfusion injury, in Acute Myocardial Infarction (Gersh BT and Rahimtoola SH eds) pp 502-548, International Thomson Publishing, New York.
12. Forman MB, Velasco CE and Jackson EK (1993) Adenosine attenuates reperfusion injury following regional myocardial ischaemia. Cardiovasc Res 27:9-17.
13. 51Cr-labeled granulocytes. J Immunol 110:233-240.
14. Gay JC, Raddassi K, Truett AP 3rd and Murray JJ (1997) Phosphatase activity regulates superoxide anion generation and intracellular signaling in human neutrophils. Biochim Biophys Acta 1336:243-253.
15. Gibbons RJ, Christian TF, Hopfenspirger M, Hodge DO and Bailey KR (1994) Myocardium at risk and infarct size after thrombolytic therapy for acute myocardial infarction: Implications for the design of randomized trials of acute intervention. J Am Coll Cardiol 24:616-623.
16. Haessler R, Kuzume K, Wolff RA, Kuzume K, Chien GL, Davis RF and Van Winkle DM (1996) Adrenergic activation confers cardioprotection mediated by adenosine, but is not required for ischemic preconditioning. Cor Art Dis 7:305-314.
17. Heller LJ and Olsson RA (1985) Inhibition of rat ventricular automaticity by adenosine. Am J Physiol 248:H907-H913.
18. Jackson EK (1997) Renal actions of purines, in Purinergic Approaches in Experimental Therapeutics (Jacobson KA and Jarvis MF eds) pp 217-250, John Wiley & Sons, New York.
19. Jackson EK, Mi Z, Koehler MT, Carcillo JA Jr and Herzer WA (1996) Injured erythrocytes release adenosine deaminase into the circulation. J Pharmacol Exp Ther 279:1250-1260.
20. Jacobson KA and van Rhee AM (1997) Development of selective purinoceptor agonists and antagonists, in Purinergic Approaches in Experimental Therapeutics (Jacobson KA and Jarvis MF eds) pp 101-128, John Wiley & Sons, New York.
21. Kitakaze M, Hori M and Kamada T (1993) Role of adenosine and its interaction with alpha adrenoceptor activity in ischaemic and reperfusion injury of the myocardium. Cardiovasc Res 27:18-27.
22. Kitakaze M, Minamino T, Funaya H, Node K, Shinozaki Y, Mori H and Hori M (1997) Vesnarinone limits infarct size via adenosine-dependent mechanisms in the canine heart. Circulation 95:2108-2114.
23. Kuan CJ, Wells JN and Jackson EK (1989) Endogenous adenosine restrains renin release during sodium restriction. J Pharmacol Exp Ther 249:110-116.
24. Kuan CJ, Wells JN and Jackson EK (1990) Endogenous adenosine restrains renin release in conscious rats. Circ Res 66:637-646.
25. 3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Cardiovasc Res 28:1057-1061.
26. Mahaffey KW, Puma JA, Barbagelata NA, DiCarli MF, Leesar MA, Browne KF, Eisenberg PR, Bolli R, Casas AC, Molina-Viamonte V, Orlandi C, Blevins R, Gibbons RJ, Califf RM and Granger CB (1999) Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction - results of a multicenter, randomized, placebo-controlled trial: The Acute Myocardial Infarction STudy of ADenosine (AMISTAD) Trial. J Am Coll Cardiol 34:1711-1720.
27. 1 receptor system. Cardiovasc Res 27:28-35.
28. 1 adenosine receptor antagonists block ischemia-reperfusion injury of the heart. Circulation 94 (Suppl II):II-376-II-380.
29. 2-receptor agonists on myocardial reperfusion injury. Am Heart J 123:332-338.
30. Norton ED, Jackson EK, Virmani R and Forman MB (1991) Effect of intravenous adenosine on myocardial reperfusion injury in a model with low myocardial collateral blood flow. Am Heart J 122:1283-1291.
31. Olafsson B, Forman MB, Puett DW, Pou A, Cates CU, Friesinger GC and Virmani R (1987) Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: Importance of the endothelium and the no-reflow phenomenon. Circulation 76:1135-1145.
32. Pitarys CJ 2d, Virmani R, Vildibill HD Jr, Jackson EK and Forman MB (1991) Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period. Circulation 83:237-247.
33. Reimer KA and Jennings RB (1979) The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 40:633-644.
34. Reimer KA and Jennings RB (1985) Failure of the xanthine oxidase inhibitor allopurinol to limit infarct size after ischemia and reperfusion in dogs. Circulation 71:1069-1075.
35. Reimer KA, Jennings RB, Cobb FR, Murdock RH, Greenfield JC Jr, Becker LC, Bulkley BH, Hutchins GM, Schwartz RP Jr, Bailey KR and the NHLBI Cooperative Study Group (1985) Animal models for protecting ischemic myocardium: Results of the NHLBI Cooperative Study: Comparison of unconscious and conscious dog models. Circ Res 56:651-665.
36. Sheehan FH, Bolson EL, Dodge HT, Mathey DG, Schofer J and Woo HW (1986) Advantages and applications of the centerline method for characterizing regional ventricular function. Circulation 74:293-305.
37. Thornton JD, Thornton CS and Downey JM (1993) Effect of adenosine receptor blockade: Preventing protective preconditioning depends on time of initiation. Am J Physiol 265:H504-H508.
38. Tofovic SP, Branch KR, Oliver RD, Magee WD and Jackson EK (1991) Caffeine potentiates vasodilator-induced renin release. J Pharmacol Exp Ther 256:850-860.
39. Todd J, Zhao ZQ, Williams MW, Sato H, Van Wylen DG and Vinten-Johansen J (1996) Intravascular adenosine at reperfusion reduces infarct size and neutrophil adherence. Ann Thorac Surg 62:1364-1372.
40. Toombs CF, McGee S, Johnston WE and Vinten-Johansen J (1992) Myocardial protective effects of adenosine: Infarct size reduction with pretreatment and continued receptor stimulation during ischemia. Circulation 86:986-994.
41. Tucker AL and Linden J (1993) Cloned receptors and cardiovascular responses to adenosine. Cardiovasc Res 27:62-67.
42. Velasco CE, Turner M, Cobb MA, Virmani R and Forman MB (1991) Myocardial reperfusion injury in the canine model after 40 minutes of ischemia: Effect of intracoronary adenosine. Am Heart J 122:1561-1570.
43. Zhao ZQ, McGee S, Nakanishi K, Toombs CF, Johnston WE, Ashar MS and Vinten-Johansen J (1993) Receptor-mediated cardioprotective effects of endogenous adenosine are exerted primarily during reperfusion after coronary occlusion in the rabbit. Circulation 88:709-719.
44. 1 receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischaemia. Cardiovasc Res 28:270-279.